Minor
ResToP · Reinduction and Second Stop of TKI With Ponatinib in CML in Molecular Response (ResToP)
Trial completed
Also in this update: Final enrollment: 34 participants (planned 80)
Fundacion CRIS de Investigación para Vencer el CáncerPhase 2 NCT04160546 Registry history of NCT04160546 on ClinicalTrials.gov (opens the registry)